Emerging nanomedicine strategies for hepatocellular carcinoma therapy
Abstract Hepatocellular carcinoma (HCC) is a prevalent malignant tumor with a range of risk factors, including viral infections, alcoholic liver disease, exposure to fungal toxins, obesity, and type 2 diabetes. Despite advancements in early detection and treatment, HCC continues to exhibit a high ra...
Saved in:
Main Authors: | Chen Guo, Jiayu Zhang, Xiaomeng Cai, Rui Dou, Jiaruo Tang, Zhengyuan Huang, Xueting Wang, Yan Guo, Hanqing Chen, Jun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | iMetaOmics |
Subjects: | |
Online Access: | https://doi.org/10.1002/imo2.12 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01) -
Recent advances in self-targeting natural product-based nanomedicines
by: Haifan Liu, et al.
Published: (2025-01-01) -
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine
by: Izadiyan Z, et al.
Published: (2025-01-01) -
Natural product virtual-interact-phenotypic target characterization: A novel approach demonstrated with Salvia miltiorrhiza extract
by: Rui Xu, et al.
Published: (2025-02-01) -
Recent updates of centromere proteins in hepatocellular carcinoma: a review
by: Zhongyuan Yang, et al.
Published: (2025-02-01)